Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia

Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes

(2015) Antonio J. Vallejo-Vaz et al.   ATHEROSCLEROSIS

Metabolite Profiling and Cardiovascular Event Risk: A Prospective Study of 3 Population-Based Cohorts

(2015) P. Wurtz et al.   CIRCULATION

Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort

(2015) Henna Cederberg et al.   DIABETOLOGIA

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

(2015) Daniel I Swerdlow et al.   LANCET

Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?

(2014) Naishi Li et al.   ATHEROSCLEROSIS

The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

(2014) Naveed A. Sattar et al.   ATHEROSCLEROSIS SUPPLEMENTS

The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism

(2014) Egon Demetz et al.   Cell Metabolism

Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease

(2014) Peter J. Meikle et al.   PHARMACOLOGY & THERAPEUTICS

Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus

(2013) Eliano Pio Navarese et al.   AMERICAN JOURNAL OF CARDIOLOGY

Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles

(2013) Marcus Ståhlman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Comparative Tolerability and Harms of Individual Statins

(2013) Huseyin Naci et al.  

Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies

(2013) M. J. Chapman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Plasma lipid profiling in a large population-based cohort

(2013) Jacquelyn M. Weir et al.   JOURNAL OF LIPID RESEARCH

TRENDS IN DOOR-TO-BALLOON TIME AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI

(2013) Angela L. Brennan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

(2013) Peter J. Meikle et al.   PLoS One

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study

(2013) Pilar Gayoso-Diz et al.   BMC Endocrine Disorders

Physiological roles of phosphatidylethanolamine N-methyltransferase

(2012) Dennis E. Vance   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance

(2012) J. Boon et al.   DIABETES

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

(2012) Paul M Ridker et al.   LANCET

Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease

(2011) Peter J. Meikle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

(2011) Stephen J. Nicholls et al.   NEW ENGLAND JOURNAL OF MEDICINE

Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo

(2010) Christopher J. Pynn et al.   JOURNAL OF LIPID RESEARCH

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study

(2010) Rishikesh Mankidy et al.   Lipids in Health and Disease

HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity

(2009) Amal Zerrad-Saadi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease

(2009) V. D. F. de Mello et al.   DIABETOLOGIA

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

(2009) M. J. Chapman et al.   EUROPEAN HEART JOURNAL

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

(2009) Philip J. Barter et al.   JOURNAL OF LIPID RESEARCH